CNSL vs. PRM, BVX, IMM, KNB, POLX, LLAI, SNG, FDBK, IHC, and INHC
Should you be buying Cambridge Nutritional Sciences stock or one of its competitors? The main competitors of Cambridge Nutritional Sciences include Proteome Sciences (PRM), BiVictriX Therapeutics (BVX), ImmuPharma (IMM), Kanabo Group (KNB), Polarean Imaging (POLX), LungLife AI (LLAI), Synairgen (SNG), Feedback (FDBK), Inspiration Healthcare Group (IHC), and Induction Healthcare Group (INHC). These companies are all part of the "medical" sector.
Cambridge Nutritional Sciences (LON:CNSL) and Proteome Sciences (LON:PRM) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, community ranking, earnings, dividends, profitability, analyst recommendations, valuation and risk.
Cambridge Nutritional Sciences has a beta of 3.87, suggesting that its stock price is 287% more volatile than the S&P 500. Comparatively, Proteome Sciences has a beta of -0.02, suggesting that its stock price is 102% less volatile than the S&P 500.
In the previous week, Proteome Sciences had 1 more articles in the media than Cambridge Nutritional Sciences. MarketBeat recorded 1 mentions for Proteome Sciences and 0 mentions for Cambridge Nutritional Sciences. Proteome Sciences' average media sentiment score of 0.25 beat Cambridge Nutritional Sciences' score of 0.00 indicating that Proteome Sciences is being referred to more favorably in the news media.
Proteome Sciences received 162 more outperform votes than Cambridge Nutritional Sciences when rated by MarketBeat users.
Proteome Sciences has lower revenue, but higher earnings than Cambridge Nutritional Sciences. Proteome Sciences is trading at a lower price-to-earnings ratio than Cambridge Nutritional Sciences, indicating that it is currently the more affordable of the two stocks.
Cambridge Nutritional Sciences has a net margin of -27.32% compared to Proteome Sciences' net margin of -48.59%. Proteome Sciences' return on equity of 0.00% beat Cambridge Nutritional Sciences' return on equity.
1.7% of Cambridge Nutritional Sciences shares are owned by institutional investors. Comparatively, 23.0% of Proteome Sciences shares are owned by institutional investors. 9.2% of Cambridge Nutritional Sciences shares are owned by company insiders. Comparatively, 19.5% of Proteome Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Summary
Proteome Sciences beats Cambridge Nutritional Sciences on 9 of the 13 factors compared between the two stocks.
Get Cambridge Nutritional Sciences News Delivered to You Automatically
Sign up to receive the latest news and ratings for CNSL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CNSL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Cambridge Nutritional Sciences Competitors List
Related Companies and Tools
